Luminary Medical Technologies

Luminor Medical Technologies is a medical diagnostic company focused on acquiring, developing, and commercializing non-invasive tests to address unmet clinical needs in Canada. The company's products and services include the PREVU Skin Cholesterol Test, a non-invasive test that measures cholesterol in skin tissue to assess the risk of coronary heart disease or heart disease, and PSP94, an enzyme-linked immunosorbent assay for urine samples. Its diagnostic projects under development include cardiovascular diseases, preeclampsia, prostate cancer, colorectal cancer, pancreatic cancer, and gastric cancer. The company has reached a cooperation agreement with Aller Company for the development of a preeclampsia biomarker test.